Beautiful Virgin Islands

Thursday, Feb 22, 2024

Once-favored Covid drugs ineffective on Omicron may be putting millions at risk

Once-favored Covid drugs ineffective on Omicron may be putting millions at risk

While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.

The lack of specialized Covid-19 treatments for people with weak immune systems has left millions of Americans with limited options if they get sick as the pandemic heads into an uncertain winter.

Once heralded as game-changers for Covid patients considered at risk for getting seriously ill — one was used to treat then-President Donald Trump in 2020 — monoclonal antibodies are now largely ineffective against current Covid variants. Easier-to-administer antiviral drugs, such as Paxlovid, have largely taken their place but aren’t safe for all immune-compromised people because they interact with many other drugs.

But the federal government funding that drove drug development in the early days of the pandemic has dried up, and lawmakers have rebuffed the Biden administration’s pleas for more. Without that, there’s little incentive for drugmakers to work on new antibody treatments that could be more effective.

And without a government program like Operation Warp Speed to develop second-generation vaccines and treatments, at-risk patients could be in danger of developing severe cases of Covid and flooding hospitals when the U.S. health care system is already strained, thanks to an influx of patients with an array of respiratory illnesses, including flu and RSV.

“Just because we have exited the emergency phase of the pandemic does not mean that Covid is over or that it no longer poses a danger,” said Leana Wen, a public health professor at George Washington University and former Baltimore health commissioner. “There are millions of Americans who are vulnerable to severe illness.”

The FDA pulled authorizations for four antibody treatments in 2022 as Omicron and its myriad subvariants wiped out their effectiveness. The treatments were geared toward adult and pediatric patients with mild-to-moderate Covid who were considered at risk of developing severe disease and ending up hospitalized.

While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.

Monoclonal antibodies — which have been made by companies like Regeneron, Eli Lilly and Vir — are lab-created molecules designed to block a virus’ entry into human cells. But they must bind to the virus’ spike protein to neutralize it, and the coronavirus’ many mutations since its 2019 emergence have gradually rendered the available products ineffective.

“It’s a bit risky to develop this,” said Arturo Casadevall of the Johns Hopkins Bloomberg School of Public Health, pointing to how quickly some Covid variants have surfaced before quickly receding.

A massive spending bill that lawmakers passed before Christmas left out the administration’s $9 billion request for more money to fight the pandemic, meaning there are fewer dollars to be spread around to address emerging Covid needs.

“Due to congressional inaction and a lack of funding, HHS does not have the resources it needs to fund the development of new treatments, and we could find ourselves with a very limited medicine cabinet at a time when we need more tools to combat Covid-19,” a department spokesperson told POLITICO, adding that HHS is working with providers and other groups “to ensure that Americans are able to take advantage of all available treatment options.”

The Biden administration has strongly promoted oral antiviral regimens like Paxlovid, which debuted a year ago and marked a turning point in managing the virus for most Americans.

Immunocompromised individuals — who are either born with immune-suppressing conditions or acquire them after organ transplants or by taking certain drugs — also may not mount sufficient immune responses after vaccination, making treatment options like antibody therapies a critical tool for them.

A CDC alert issued Dec. 20 to clinicians and public health professionals warned of the lack of viable monoclonal antibody treatments — including the diminished efficacy of a prophylactic antibody, Evusheld — and the availability of the antiviral options that to date have seen lackluster uptake. The agency urged providers to consult the National Institutes of Health’s Covid treatment guidelines for ways to potentially manage drug interactions with Paxlovid, such as temporary pauses or reductions in dose.

Remdesivir, an antiviral administered intravenously, is another treatment option for the immunocompromised, but it requires infusions over three days in either hospital or outpatient settings. HHS is urging states to support its health departments and systems in setting up infusion clinics to expand access to remdesivir, especially on an outpatient basis, and is working with maker Gilead to broaden the types of providers eligible to buy the drug.

Covid convalescent plasma remains an option for immunocompromised people who contract the virus, but its availability is scattershot across the country, Casadevall said. The treatment has pros and cons, he said — it’s less likely to be defeated by any one variant and can adapt to different strains, but it’s difficult to administer and requires blood-typing to be done for the recipient.

Still, Casadevall said, the main issue is educational because its use has changed since the pandemic’s early days, when treatments were scarce. Some hospital systems, like Hopkins, use it routinely, while some doctors don’t know plasma is still an option, he said.

The FDA has authorized the emergency use of convalescent plasma containing high Covid antibody levels for immunocompromised patients. But NIH has remained neutral on the treatment in that population, which Janet Handal, president of the Transplant Recipients and Immunocompromised Patient Advocacy Group, says has led to some hospitals balking at administering it.

NIH spokesperson Renate Myles pointed to the agency’s treatment guidelines for Covid, which are developed by an expert panel.

The recommendations for Covid convalescent plasma, last updated on Dec. 1, say there’s “insufficient evidence” to recommend for or against the treatment’s use in immunocompromised patients, while noting some panel members would use plasma to treat an immunocompromised person “with significant symptoms attributable to COVID-19 and with signs of active [viral] replication and who is having an inadequate response to available therapies.”

“In these cases, clinicians should attempt to obtain high-titer [Covid convalescent plasma] from a vaccinated donor who recently recovered from Covid-19 likely caused by a … variant similar to the variant causing the patient’s illness,” the guidelines say.

Casadevall, who leads the Covid-19 Convalescent Plasma Project, says NIH’s stance on plasma is inconsistent with its previous recommendations of monoclonal antibodies, which were made without clinical efficacy data, since Covid antibodies are the active component in both therapies. He led a petition earlier this month — signed by several doctors, including past and current presidents of the Infectious Diseases Society of America — asking NIH to change its recommendations.

Handal’s group also has asked the NIH and the White House to convene a meeting with scientists on the issue.

“To just not be having a dialogue about it is infuriating to us,” Handal said. “People are dying while people are just going through this bureaucratic dance.”

The FDA and European Medicines Agency held a virtual workshop this month to bring doctors, industry and regulators together to discuss supporting novel monoclonal antibody treatments.

“The FDA is committed to working with industry sponsors to expedite the development of new drug products to meet unmet needs, such as the need for new preventive therapies for immune-suppressed patients who are unlikely to respond to vaccination,” an agency spokesperson said.

In the meantime, Regeneron spokesperson Tammy Allen said the company, whose antibody cocktail’s use was limited in January, is committed to evaluating antibody treatment options as the coronavirus evolves.

“We believe monoclonal antibodies have played an important role in the COVID-19 pandemic to date and may again in the future, particularly among people with immunocompromising conditions,” Allen said.

Vir, which partnered with GSK on sotrovimab, continues to study whether the treatment could work against emerging variants and is also evaluating next-generation antibodies and small-molecule therapies, said spokesperson Carly Scaduto.

Still, pharmaceutical companies may be more inclined — both financially and practically — to pursue

developing better antiviral pills that pose fewer drug interactions and are easier to administer, said Jason Gallagher, a clinical pharmacy specialist in infectious diseases at Temple University Hospital. Antivirals also hold up better against an ever-changing virus, he added.

“There’s way more money in Paxlovid than there is in any monoclonal” antibody treatment, Gallagher said, and it may take incentives to drugmakers to encourage their development. “They’re not going to make anyone really rich.”

Newsletter

Related Articles

Beautiful Virgin Islands
London's Iconic British Telecom Tower Sold To Become Hotel
I have a dream, MLK inspiring speech
Ukraine Arrests Father-Son Duo In Lockbit Cybercrime Bust
Aretha Franklin, Marvis Staples - Oh Happy Day
US Offers $15 Million For Info On Leaders Of Cybercrime Group Lockbit
BVI Freedom Song
Russia Claims UK Cultural Agency Spied for Ukraine
Billy Preston - You Can't Beat God Giving (Live)
Apple warns against drying iPhones with rice
VIRGIN ISLANDS REGGAE CARIBBEAN RIDDIMZ
Alexei Navalny: UK sanctions Russian prison chiefs after activist's death
Oh Happy Day Edwin Hawkins - Anthony Brown w FBCG Combined Choir
German economy is in 'troubled waters' - ministry
'Stand by Me' performed by Karen Gibson and The Kingdom Choir
In a recent High Court hearing, the U.S. argued that Julian Assange endangered lives by releasing classified information.
National Anthem of the British Virgin Islands - Oh, Beautiful Virgin
New video
Hello Dolly
Tucker Carlson says Boris Johnson wants "a million dollars, in Bitcoin or cash, from Tucker Carlson to talk about Ukraine.
for KING & COUNTRY - Amen (Reborn) [feat. Lecrae & The WRLDFMS Tony Wi
Russia is rebuilding capacity to destabilize European countries, new UK report warns
Bob Marley - Get Up Stand Up
EU Commission wants anti-drone defenses at Brussels HQ
Yes He Can
Von der Leyen’s 2nd-term pitch: More military might, less climate talk
What A Friend We Have In Jesus
Global Law Enforcement Dismantles Lockbit Ransomware Operation
Unforgettable
Prince William Urges End to Gaza Conflict
Touch The Hem Of His Garment
UK court to hear Assange's final appeal against extradition to the US, where he faces charges related to his journalistic work—the publication of a classified video in 2010 that exposed US war crimes against humanity.
The Lord's Prayer
About 50-60% kids either chose to be YouTuber or influencer
THE GOD MOVEMENT...BEAUTIFUL BVI
A viral video of Nationals MP Barnaby Joyce lying on a Canberra footpath is celebrated by his media mates.
Siyahamba
European Countries React to Navalny's Death by Summoning Russian Diplomats
Ray Charles And The Voices Of Jubilaton, Oh, Happy Day
Israel has gone ‘beyond self-defence’ in Gaza, says Labour’s Streeting
Ramblin' Rose
English farmers to be offered ‘largest ever’ grant scheme amid food security concerns
Protoje - Who Knows ft. Chronixx
Cameron government knew Post Office ditched Horizon IT investigation
Pressure - Virgin Islands Nice
EU Calls for Immediate Ceasefire in Gaza Conflict
Phil Wickham - House Of The Lord
EU Vows To Hold Putin "Accountable" After Meeting Alexei Navalny's Wife
My God Is Real (Yes, God Is Real)
EU Launches Probe Into TikTok Over Child Protection Under Digital Content Law
The Lion King Circle of Life by LEBO M. — LIVE at the HAVASI Symphonic
The EU Initiates Naval Mission to Defend Red Sea Trade Routes
Louis Armstrong - When The Saints Go Marching In
EU and UK Announce Joint Effort on Migration
Kanye West Sunday Service - hallelujah, salvation, and glory
Brazil's Lula Likens Gaza Operation to Holocaust, Israel Says "Red Line" Crossed
Jonathan Nelson - I Believe (Island Medley
Ministers Confirm Proposal to Prohibit Mobile Phone Usage in English Schools
From The Virgin Islands Sqad Up
Microsoft-backed OpenAI valued at $80bn after company completes deal
Common, John Legend - Glory
‘Alexei would want to tell Russia not to give up fighting’
Anthony Evans vs. Jesse Campbell - If I Ain't Got You
Rwandan Footballer's Dismissal Sparks Concerns Over UK Asylum Plan
I have a dream, MLK inspiring speech
Whisky Challenges China's Baijiu Market During New Year Celebrations
Aretha Franklin, Marvis Staples - Oh Happy Day
Avdiivka - Symbol Of Ukrainian Resistance Now In Control Of Russian Troops
BVI Freedom Song
Putin Critic Alexei Navalny's "Killers" Refusing To Hand Over Body, Say Allies
Billy Preston - You Can't Beat God Giving (Live)
"Historic Step": Zelensky Signs Security Pact With Germany
VIRGIN ISLANDS REGGAE CARIBBEAN RIDDIMZ
"Historic Step": Zelensky Signs Security Pact With Germany
Oh Happy Day Edwin Hawkins - Anthony Brown w FBCG Combined Choir
20 Tech Giants Sign Effort To Fight AI Election Interference Across Globe
'Stand by Me' performed by Karen Gibson and The Kingdom Choir
Joe Biden Accuses Putin of Causing Navalny's Death
National Anthem of the British Virgin Islands - Oh, Beautiful Virgin
Russian opposition leader Alexey Navalny has died at the Arctic prison colony
Hello Dolly
Tucker Carlson grocery shopping in Russia. This is so interesting.
for KING & COUNTRY - Amen (Reborn) [feat. Lecrae & The WRLDFMS Tony Wi
Julian Assange's Wife Warns of His Death if Extradited to US
Bob Marley - Get Up Stand Up
‘A lot higher than we expected’: Russian arms production worries Europe’s war planners
Yes He Can
Greece Legalizes Same-Sex Marriage and Adoption Rights
What A Friend We Have In Jesus
Hungarian Foreign Minister: Europeans will lose Europe, the Union's policy must change drastically
Unforgettable
In Britain Homeowners are receiving CPO’s (Compulsory Purchase Orders) so their homes can be redistributed to migrants
Touch The Hem Of His Garment
Microsoft says it caught hackers from China, Russia and Iran using its AI tools
The Lord's Prayer
Influencers Exploit X Platform for Profit Amidst Israel-Gaza Conflict
THE GOD MOVEMENT...BEAUTIFUL BVI
Former Dutch PM And Wife Die "Together Hand In Hand" Via Duo Euthanasia
Siyahamba
Media Giant Paramount Global, Which Owns CBS News, To Cut 800 Jobs
Ray Charles And The Voices Of Jubilaton, Oh, Happy Day
×